2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$10.50$0.00 (0.00%)
Price as of Jun 03, 2026 4:10 PM EDT- $222.7MMarket Cap
- -29.43%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$10.50$0.00 (0.00%)
KROS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.50 | ||
Change | -$0.35 (-3.21%) | ||
Open | $10.55 | ||
High | $10.57 | ||
Low | $10.38 | ||
Previous Close | $10.55 | ||
Volume | 190,322 | ||
30-Day Average Volume | 351,374 | ||
1-Week Change | -6.06% | ||
1-Month Change | -8.18% | ||
1-Year Change | -29.43% | ||
3-Year Change | -78.54% | ||
5-Year Change | -78.27% | ||
Fundamentals | |||
Shares Outstanding | 19.8M | ||
Total Assets | $312.3M | ||
Market Cap | $222.7M | ||
Enterprise Value | -$58.8M | ||
Period: QTR TTM FY | |||
Revenue | $367,000.00 | ||
Net Income | -$23.7M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$23.7M | ||
EBITDA | -$23.3M | ||
Net Working Capital | $277.8M | ||
EPS | -$1.21 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -160 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -62 | ||
Price/Operating Cash Flow | -63 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue